Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-07-02-2002
Volume26
Issue 7

Congress Adopts New User Fee Program

Author(s):

To fund expanded FDA operations designed to streamline drug development and approval, FDA and industry representatives have negotiated the Prescription Drug User Fee Act III.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
 Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
© 2025 MJH Life Sciences

All rights reserved.